Summary The effects of expressing neu-T, a mutated constitutively activated form of c-neu, have been examined in the non-transformed conditionally immortalised human mammary luminal epithelial cell line, HB4a. A variant cell line, N4.1, which expressed neu-T, showed evidence of transformation, including partial loss of growth factor dependence and acquisition of anchorage-independent growth, but failed to give rise to tumours in nude mice, indicating that expression of neu-T alone was probably insufficient to cause tumorigenic progression to a full malignant phenotype. During characterisation of the N4.1 cell line, it was observed that under conditions of serum deprivation, it underwent apoptotic cell death, as demonstrated by light microscopy, flow cytometry and DNA gel electrophoresis. The induction of apoptotic cell death in the N4.1 cell line by serum deprivation was abrogated specifically by the addition of steroids with glucocorticoid activity but not any peptide growth factors studied. This study shows the induction of apoptosis by serum deprivation, and its abrogation by glucocorticoids occurring in human mammary luminal epithelial cells transformed by expression of neu-T, and implicates the involvement of receptor protein tyrosine kinases in an apoptotic signalling pathway in this cell type.
c-erbB-2 is a member of a gene family encoding membranespanning receptor protein tyrosine kinases (Yamamoto et al., 1986; Ullrich and Schlessinger, 1990 ) and consists of three major structural domains: the extracellular ligand-binding domain, the transmembrane domain and the intracellular kinase domain. Overexpression of c-erbB-2 has been reported in 25-30% of human breast cancers and is associated with both a poor response to therapy and an overall reduced survival rate (Gullick et al., 1991; Gusterson et al., 1992) . The overexpression of c-erbB-2 is thought to lead to dimerisation of the receptor, resulting in its constitutive autophosphorylation and activation of the protein tyrosine kinase domain. In addition to overexpression, an alternative means of activation of the protein tyrosine kinase domain has been reported for c-neu, the rat homologue of c-erbB-2. A mutated form of c-neu, referred to here as neu-T, isolated from chemically induced neuro-and glioblastomas, has been found to contain a single, specific point mutation in the transmembrane domain that results in the constitutive activation of the protein tyrosine kinase domain (Schechter et al., 1984) .
Overexpression of c-erbB-2, or expression of neu-T, is sufficient to transform the NIH 3T3 mouse fibroblast cell line (DiFiore et al., 1987; Hudziak et al., 1987) . Expression of neu-T in vivo can give rise to tumours in transgenic mice. However, there are conflicting reports as to whether the presence of neu-T is sufficient or merely necessary for the development of malignancy in these models (Muller et al., 1988; Bouchard et al., 1989) . Few investigations have been performed on human mammary luminal epithelial cells, which are the site of origin of the majority of human breast cancers, but these have suggested that when c-erbB-2 is overexpressed to high levels, tumorigenic transformation can result (Pierce et al., 1991) .
In the present work, the mutated constitutively active neu-T was introduced into the conditionally immortalised human al., 1994) , to evaluate the transforming potential of the gene. During the characterisation of the variant cell lines produced, it was observed that, under certain conditions, expression of neu-T can also lead to the induction of apoptosis, and that this can be abrogated by glucocorticoid hormones.
Materials and methods
Chemicals and reagents RPMI-1640 cell culture medium and the antibiotics penicillin and streptomycin were purchased from ICN Flow (High Wycombe, Bucks, UK), fetal calf serum from Bioclear (Devizes, Wiltshire, UK), Transfectam reagent from Promega (Chilworth, Southampton, UK), Nucleon DNA extraction kit from Scotlab (Coatbridge, Strathclyde, U.K.), EcoRI and XbaI restriction endonucleases from Gibco Life Technologies (Paisley, Renfrewshire, U.K.), 'Quik-hyb' solution and 'Prime-it' kit from Stratagene (Cambridge Science Park, Cambridge, UK), c-neu Ab-3 and c-neu Ab-4 antibodies from Oncogene Science (Stourbridge Common, Cambridge, UK), RC20 antibody from Transduction Laboratories (Affiniti, GPT Business Park, Nottingham, UK), streptavidin fluorescein protein and ECL chemiluminescence system from Amersham Life Science (Little Chalfont, Buckinghamshire, UK), Immobilon-P transfer membrane from Millipore (Bedford, MA. USA), Noble agar from Difco Laboratories (Detroit, MI, USA), Matrigel from Collaborative Biomedical Products (Bedford, MA, USA) and Epon-Araldite (Agar Scientific) and all other reagents from Sigma (Poole, Dorset, UK).
Cell culture and isolation of variant cell lines The derivation of the HB4a cell line using an amphotrophic retroviral vector to transduce the tsA58-U19 recombinant mutant SV40 large T antigen gene into FAC-sorted normal human mammary luminal epithelial cells has been described previously (Stamps et al., 1994) . Cells were routinely cultured at 37C in phenol red-containing RPMI-1640 medium supplemented with 10% (v/v) fetal calf serum (FCS), 5 gg ml-' hydrocortisone, 5tLgml-' insulin and lOOngmlhl cholera toxin plus penicillin and streptomycin (complete medium) as described for the establishment and clonal growth of normal human mammary cells (O'Hare et al., 1991) . The DNA expression construct pSV2neu-T contains a cDNA corresponding to the full-length mutated rat neu-T sequence, under the control of the SV40 early promoter. Transfection of plasmids into the HB4a cell line at passage 30 after establishment was performed using the lipid-based reagent, Transfectam, according to the manufacturer's instructions. For selection purposes, pSV2neu-T was co-transfected with the drug selection plasmid pSV2hyg, which contains the hygromycin B resistance sequence, in a 5:1 ratio, since the HB4a cell line already carries the neomycin resistance gene. Control cultures were transfected with pSV2hyg only. Transfected cells were allowed to grow for 1 week in complete growth medium before drug selection (50 jg ml-' hygromycin B). After 3-4 weeks individual colonies were isolated by ring cloning and expanded.
Molecular characterisation of neu-T-expressing cell lines Ten micrograms of genomic DNA was prepared from neu-Texpressing cell lines using the Nucleon kit and digested with EcoRI and XbaI. Southern blotting was performed on the digested DNA (Sambrook et al., 1989) and the blots were hybridised with a 32P-labelled, random primed, c-neu cDNA probe (labelled with the 'Prime-it' kit), and hybridised in 'Quik-hyb' solution. Total RNA was prepared from cell lines using guanidinium thiocyanate (Chomczynski and Sacchi, 1987 (Harlow and Lane, 1988) . After SDS-PAGE, proteins were transferred to Immobilon-P transfer membrane by conventional wet blotting technique (Harlow and Lane, 1988 Analysis of apoptosis Cells which had detached into the growth medium were harvested by centrifugation at 1800 r.p.m. for 5 min at room temperature. The resulting cell pellets were prepared as for electron microscopy by fixation with 2.5% (v/v) glutaraldehyde in PBS. After fixation cell pellets were treated for 1 h in 1% (w/v) osmium tetroxide, dehydrated through a series of graded ethanols and embedded in Epon-Araldite as described by Ormerod et al. (1994) . Sections of 1 pm were then cut, dried onto a glass slide and stained with 1% (w/v) toluidine blue in 1% (v/v) borax before visualisation by light microscopy. To determine DNA degradation, cells were harvested from both the supernatant growth medium and cell monolayer, and genomic DNA prepared (Catchpoole and Stewart, 1993) . The internucleosomal fragmentation of DNA obtained was assessed by the presence of laddering using the 32P end-labelling method described by Rosi et al. (1992) . Flow cytometry was used to record DNA histograms produced by cells fixed with 70% ethanol (v/v) and stained with propidium iodide (Ormerod et al., 1992) .
Results

Isolation of variant cell lines
The transforming potential of neu-T expression was assessed by transfection of pSV2neu-T, together with pSV2hyg, into the non-transformed immortalised human mammary luminal epithelial cell line, HB4a. After a period of drug selection lasting 2 weeks, drug-resistant clones were picked at random and screened by indirect immunofluorescence. neu-T expression was detected in two out of four clones screened in this manner. These two neu-T-expressing clones, N4.1 and N4. Immunoprecipitation experiments showed that the neu-T protein expressed in these cell lines was phosphorylated on tyrosine residues, indicating that, as expected, the protein is constitutively kinase active (Figure 2 ). FACS analysis of live cells showed expression of neu-T in the N4.1 and N4.2 cell lines at the cell surface. Using the same method, the H4. 1 cell line gave a mean FACS channel value approximately equal to that seen with a control sample, where the c-neu-specific first antibody (NFA) had been omitted, confirming that this human cell line does not react with the antibody against rodent c-neu, while both neu-T-expressing variant cell lines showed elevated values. The mean FACS channel values were: NFA = 34, H4.1 = 37, N4.1 = 191, N4.2 = 131 on an arithmetic (non-log) scale. Owing to its higher levels of neu-T expression, N4. 1 was selected for further detailed characterisation.
Effect of neu-T expression on cell growth and tumorigenicity The growth characteristics of the N4.1 cell line were initially studied using single-point growth experiments over a fixed time period of 7 days (Figure 3) . These experiments showed that in complete growth medium the N4. 1 cell line grew faster and reached much higher cell densities than the H4.1 cell line, indicating a loss of contact inhibition of growth. Similar experiments performed in basal medium (i.e. without hydrocortisone, insulin and cholera toxin) revealed that the N4.1 cell line continued to proliferate to confluence, while the H4.1 cell line (like the parental HB4a cell line) arrested before this point, indicating that the N4. 1 cell line had acquired reduced growth factor dependency. Proliferation rates were examined by multipoint growth curves from which the doubling times in the exponential growth phase were calculated. In complete growth medium, the N4.1 cell line was found to have a much shorter doubling time (36 h) than the H4.1 cell line (68 h), the latter being very similar to the parental HB4a cell line. Further examination of the reduction in growth factor dependency of the N4.1 cell line showed that, while the addition of hydrocortisone and insulin to growth medium acted synergistically in the promotion of proliferation and overgrowth, the presence of cholera toxin reduced both the proliferative rate and the final cell density. (1, complete).
In contrast, cholera toxin stimulated the proliferation of the H4.1 control cell line, again like the parental stocks of HB4a (Figure 3 ). These changes in growth characteristics were also observed, but to a lesser extent, in the N4.2 cell line, which expressed lower levels of neu-T on the cell membrane (see above). The N4.1 cell line displayed altered growth properties in vitro compared with the control cell line which had undergone a similar process of selection, isolation and expansion, which indicated that neu-T expression had resulted in transformation of the cells. This was tested further by analysing anchorage-independent growth and growth as xenografts. While the H4.1 cell line gave colonies in soft agar at only very low efficiency (0.15% ± 0.08 s.d.), the N4.1 cell line produced colonies with a diameter greater than 0.5 mm at almost 100-fold higher efficiency (12.16% ± 1.81 s.d.). However, when assayed for tumorigenic transformation in vivo, by subcutaneous injection into either nude or SCID mice, neither the H4.1 cell line nor the N4.1 cell line produced tumours in 20 animals inoculated (15 nudes and five SCIDs).
Induction of apoptosis by serum withdrawal in cells transformed by neu-T expression and its abrogation by glucocorticoids Since, when cultured in serum-containing medium, the N4.1 cell line clearly showed reduced requirements for exogenous 6 r Tr growth factors, the effects of reduced serum concentrations were examined. In low-serum medium (LSM; RPMI-1640 medium containing 0.2% (v/v) fetal calf serum) the H4.1 cell line entered growth arrest (this was proved to be quiescence since addition of complete medium to H4.1 cells arrested with LSM caused them to recommence growth: data not shown), while the N4. 1 cell line underwent extensive cell death. This showed all the hallmarks of apoptosis: loss of cell-cell contact, membrane blebbing, cytoplasmic condensation, and eventually cell fragmentation, resulting in the presence of a large number of small, membrane-bounded apoptotic bodies in the supernatant medium (Figure 4a and b). These supernatants were collected, and examination of the fixed cells by high-resolution light microscopy revealed that the chromatin they contained had become marginalised and condensed (Figure 4d) . Apoptosis of the N4.1 cell line was evident after 3 days in LSM. By contrast, the supernatant fraction obtained from the H4.1 cell line under the same conditions was much smaller and contained only cell debris which showed no obvious signs of apoptosis ( Figure  4c ). To examine the time course of apoptosis, the effects of serum withdrawal on the N4.1 cell line were investigated further by measuring the condensation of the chromatin associated with apoptosis. Samples were taken, at daily intervals, from cultures of the H4.1 and N4.1 cell lines that had been maintained in LSM, and the DNA content of these cells was analysed by flow cytometry after staining with propidium iodide ( Figure 5 ). On day 1 of the experiment, both the H4.1 and the N4.1 cell lines produced DNA histograms containing the expected GI, S-phase and G2/M populations.
By day 5, the H4.1 cell line showed a reduction in both S-phase (from 33% to 0% of the total cell population) and G2 (from 26% to 10%) populations, indicating G1 arrest. The N4.1 cell line continued to show an S-phase fraction (albeit reduced from 17% to 4% of the total cell population) with a reduced G2 population (from 33% to 5%) and the appearance of a sub-GI peak (14%), which has been observed in other examples of apoptosis (Ormerod et al., 1992) .
Another parameter associated with apoptotic cell death is the internucleosomal cleavage of DNA. The H4.1 and the N4.1 cell lines were, therefore, compared using a sensitive radiolabelling method. Cell lines were cultured in LSM and again sampled at daily intervals. Substantial internucleosomal fragmentation was evident in the N4.1 cells sampled from day 3 onwards, while in contrast, even after 5 days, little or H4. 1 0 no such specific cleavage of DNA was seen in the H4.1 cell line (Figure 6 ).
To ascertain whether exogenous growth factors were capable of preventing apoptosis, a series of multiwell experiments were performed, in which the adherent cells and hence the amount of proliferation or apoptosis was assessed by fixing and staining cells with methylene blue. This protocol was used to study the effects of a wide range of peptide growth factors and hormones added to LSM. These included insulin, epidermal growth factor (EGF), nerve growth factor (NGF), acidic fibroblast growth factor (a-FGF), basic fibroblast growth factor (b-FGF), transforming growth factor alpha (TGF-x) and transforming growth factor beta (TGF-P) (all tested in replicate at a range of concentrations between 100 and 0.01 tg ml-) as well as hydrocortisone, dexamethasone, corticosterone, aldosterone, deoxycorticosterone, oestrone, oestradiol, progesterone, testosterone, androstenedione and dehydroepiandrosterone (all initially tested at a concentration of 3 tiM). Only hydrocortisone and other steroids with glucocorticoid activity (e.g. dexamethasone, corticosterone and, to a lesser extent, aldosterone) were found to inhibit the induction of apoptosis and promote proliferation of the N4.1 cell line. The oestrogens, androgens and their precursors were all inactive, as was progesterone. A dose-response study using hydrocortisone showed that this anti-apoptotic effect could be produced by concentrations equivalent to those seen physiologically (20-100 ng ml-') ( Figure 7 ).
Discussion
The initial aim of this present study was to define further the role of c-erbB-2 in the progression of malignancy in human breast tumours. neu-T, the mutated, constitutively active rat homologue of c-erbB-2, was expressed in the conditionally immortalised human mammary luminal epithelial cell line, HB4a, to enable comparisons to be made with other forms of the receptor. Expression of neu-T was found to cause alterations in cellular morphology and growth characteristics in variant cell lines found to express detectable surface p185neu-T.
In one such variant, N4.1, these changes included an increase in proliferative rate, an increase in saturation density, a reduction in growth factor requirements, the acquisition of anchorage-independent growth and an altered response to cholera toxin as seen in other transformed cells (Pastan and Willingham, 1978) . However, neither the N4.1 cell line nor a variant of the HB4a cell line transformed with point mutated c-Ha-ras (R4.2) (data not shown) produced tumours in nude mice. This failure to acquire a fully malignant phenotype in vivo has also been observed in studies with these oncogenes using the spontaneously immortalised, non-transformed human mammary epithelial cell line, MCF-1OA (Ciardellio et al., 1992; Normanno et al., 1994) . This is in contrast to with the findings of D'souza et al. (1993) , and shows that the role of c-erbB-2 overexpression (or mutationally activated neu-T) in the acquisition of tumorigenicity in human mammary epithelial cells is as yet unresolved. However, an unexpected observation was that the neu-T-expressing cell lines underwent a marked apoptotic response when serum levels were reduced to 0.2% (v/v) in another transformation assay.
Apoptosis, or programmed cell death, is a mode of physiological cell death characterised by the condensation of chromatin around the nuclear periphery and the cleavage of DNA into oligonucleosome-size fragments by an endogenous endonuclease. During apoptosis, cells exhibit extensive blebbing of the plasma membrane accompanied by nuclear and cytoplasmic budding to produce dense, membrane-bounded apoptotic bodies (Kerr et al., 1972; Arends and Wyllie, 1991 , 1993) . Apoptosis also occurs naturally during involution of the lactating rodent mammary gland following weaning (Walker et al., 1989) and in the human breast epithelium during the menstrual cycle (Anderson et al., 1982) . However, no specific mechanisms that induce or inhibit apoptosis in the normal mammary gland have yet been identified, although studies with the MCF-7 cell line have indicated that oestrogen withdrawal may promote apoptosis in xenografts of some stocks of this cell line (Kyprianou et al., 1991) . Apoptotic cell death was not observed in vitro with this cell line. In the present study the N4.1 cell line was found to undergo rapid and extensive apoptotic cell death when deprived of serum in culture. Although the induction of apoptosis by serum withdrawal has been described for fibroblast cell lines transformed by proto-oncogene expression (Evan et al., 1992) , a link between receptor protein tyrosine kinases and apoptosis in epithelial cells has not previously been reported.
The N4.1 cell line has an increased growth rate in serumcontaining medium when compared with a control cell line cn _A (H4. 1). This is consistent with the model that expression of neu-T promotes entry into the cell cycle by constitutively activating mitogenic signalling pathways. The removal of serum growth factors signals growth arrest, and it is conceivable that it is the reception of these two incompatible growth-regulatory signals that causes the N4.1 cell line to undergo apoptosis upon serum withdrawal. This 'conflict hypothesis' was put forward by Evan et al. (1992) to explain a similar response seen with Rat-I fibroblasts transformed by c-myc. Recently, the 'conffict hypothesis' for the induction of apoptotic cell death has been taken further (Evan and Littlewood, 1994) to produce the 'dual hypothesis', which implies that a protein may have dual function, performing either a proliferative or apoptotic role depending on the cellular environment. Thus, in the present study, the expression of neu-T produces proliferation in the presence of serum, while in the absence of serum it results in apoptosis. These studies indicate that the expression of neu-T can have a dual function, and provides additional evidence that, although as yet ill-defined, the signalling pathways for cellular proliferation, differentiation and death are linked (Yonish-Rouach et al., 1993) . Since neu-T is known to act upstream of c-Ha-ras in the mitogenic signal transduction pathway (Ben-Levy et al., 1994) , the observation that a variant of the HB4a cell line R4.2 transformed by point mutated c-Ha-ras does not appear to undergo apoptosis in low-serum medium (data not shown) suggests that the apoptotic signalling pathway in this system is not dependent on activation of c-Ha-ras.
The capacity to undergo apoptosis may have contributed to the failure of the N4.1 cell line to produce tumours in nude mice, and indicates that, to progress to a fully malignant phenotype in vivo, additional genetic alterations are necessary. One mutational event commonly found in a wide range of human malignancies, including breast cancer, is the inactivation of the tumour suppressor p53 (Hollstein et al., 1991) . p53 has been implicated in apoptotic cell death (Yonish-Rouach et al., 1991) . However, since p53 function is known to be impaired by the presence of the SV40 large T antigen (Segawa et al., 1993) , which is present and active in the HB4a cell line under the conditions used in this study, it is likely that the serum withdrawal-induced apoptosis observed in the N4. 1 cell line occurs in a p53-independent manner. Previous studies, using fibroblast and haemopoietic cell lines, have shown that growth factors such as insulin-like growth factor I (IGF-I) (Harrington et al., 1994) and colonystimulating factors (CSFs) (Williams et al., 1990) , respectively, are effective in inhibiting apoptosis. However, in the current study, the ability to prevent apoptosis induced by serum withdrawal in the epithelially derived N4.1 cell line was found only with glucocorticoids. Glucocorticoids have been shown to increase the stability of c-erbB-2 mRNA transcripts and strongly stimulate the expression of the epidermal growth factor receptor (c-erbB-l) (Ewing et al., 1989; Karlan et al., 1994) . It is possible that, by stabilising and increasing the expression of erbB family members, glucocorticoids enhance the mitogenic signals produced, even in conditions in which ligands are limiting, such as those experienced during serum withdrawal. Added EGF, however, did not by itself abrogate apoptosis in this system. This glucocorticoid abrogation of epithelial apoptotic cell death stands in marked contrast to its role in inducing thymocyte programmed cell death (Wyllie, 1980) but is in accordance with the finding that glucocorticoids inhibit the apoptotic cell death involved in the involution of the mouse mammary gland (Ossowski et al., 1979) .
Although expression of neu-T does not directly mimic the overexpression of c-erbB-2 observed in many breast tumours, the N4.1 cell line described above does provide a reproducible model linking receptor protein tyrosine kinases to in vitro transformation and the induction of apoptosis in human mammary luminal epithelial cells. A fuller understanding of the signalling pathways involved in apoptotic cell death in such cells might enable future drugs to be designed specifically to activate these pathways since many current therapeutic agents have been shown to cause cell death by apoptosis (Hickman, 1992) .
